This came after the drug major Sun Pharma Laboratories presented the proposal to conduct Phase III clinical trial titled “A ...
The discovery could significantly reduce the production costs of fuels, chemicals, and materials. A research team from the Twin Cities College of Science and Engineering and the University of ...
About ORLADEYO ® (berotralstat) ORLADEYO ® (berotralstat) is the first and only oral therapy designed specifically to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients 12 ...
What is the ‘golden dose’ and what are the risks? Medical News Today asks four experts to weigh in on the trend of trying to ...
Terns Pharmaceuticals has shelved its oral GLP-1 obesity candidate after a phase 2 trial delivered a mix of weight loss and ...
Novo Nordisk announced its oral GLP-1 has been approved by the FDA to reduce risk for major adverse cardiovascular events in ...
Polypills for HFrEF are being tested in RCTs, and if they’re approved, experts want to be ready for their rollout and use.
New study tests civet coffee's $75 price. Researchers found higher fat and two flavor compounds, but caffeine and protein ...
People are trying mini doses of GLP-1 drugs to lose weight or maintain weight loss, but doctors urge caution, calling the ...
Yutrepia was well tolerated and improved 6-minute walk distance and cardiac effort at 16 weeks in patients with pulmonary ...
Mail has revealed the common questions, mistakes, themes and topics of the five most popular QCAA general exams.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback